Legal Representation
Attorney
GLENN A GUNDERSEN
USPTO Deadlines
Application History
50 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 26, 2026 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Jan 26, 2026 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Jan 21, 2026 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Aug 4, 2025 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Aug 4, 2025 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Aug 4, 2025 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Aug 4, 2025 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Aug 4, 2025 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Aug 4, 2025 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Feb 4, 2025 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Dec 10, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Dec 10, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Dec 4, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Oct 15, 2024 | EXPT | T | EXPARTE APPEAL TERMINATED | Loading... |
| Oct 15, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 6, 2024 | GNS1 | O | NOTIFICATION OF SUBSEQUENT FINAL EMAILED | Loading... |
| Sep 6, 2024 | GNSF | O | SUBSEQUENT FINAL EMAILED | Loading... |
| Sep 6, 2024 | CFRC | R | SUBSEQUENT FINAL REFUSAL WRITTEN | Loading... |
| Jul 15, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jul 15, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jul 15, 2024 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| May 2, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| May 2, 2024 | GNSL | F | LETTER OF SUSPENSION E-MAILED | Loading... |
| May 2, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| May 1, 2024 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| May 1, 2024 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| May 1, 2024 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| May 1, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Jan 26, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Jan 26, 2024 | ERSI | I | TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED | Loading... |
| Dec 29, 2023 | GNS3 | O | NOTIFICATION OF LETTER OF SUSPENSION E-MAILED | Loading... |
| Dec 29, 2023 | GNSL | S | LETTER OF SUSPENSION E-MAILED | Loading... |
| Dec 29, 2023 | CNSL | R | SUSPENSION LETTER WRITTEN | Loading... |
| Dec 5, 2023 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| Dec 5, 2023 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
| Dec 5, 2023 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| Dec 5, 2023 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
| Aug 28, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Aug 28, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Aug 25, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Aug 25, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Aug 25, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jun 5, 2023 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Jun 5, 2023 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Jun 5, 2023 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Apr 13, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Apr 12, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Apr 12, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Oct 12, 2022 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Oct 12, 2022 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
Detailed Classifications
Class 042
Pharmaceutical research and development in the field of cancer and autoimmune disease; pharmaceutical drug development and discovery services in the field of cancer and autoimmune disease; scientific research in the field of pharmaceuticals; providing scientific research information in the field of pharmaceuticals; none of the foregoing relating to gastrointestinal issues
First Use Anywhere:
Apr 27, 2020
First Use in Commerce:
Apr 27, 2020
Classification
International Classes
042
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
Specific Disclaimer
"THERAPEUTICS"